Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantation: Hematological Oncology

A.J.M. Ferreri, M. Sassone, P. Angelillo, F. Zaja, A. Re, A. Di Rocco, M. Spina, A. Fabbri, C. Stelitano, M. Frezzato, S. Volpetti, R. Zambello, C. Rusconi, D. De Lorenzo, E. Scarano, A. Arcari, G. Bertoldero, A. Nonis, T. Calimeri, S. PerroneC. Cecchetti, V. Tarantino, S. Steffanoni, M. Foppoli, F. Ciceri, M. Ponzoni

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantation: Hematological Oncology'. Together they form a unique fingerprint.

Medicine & Life Sciences